logo
ResearchBunny Logo
A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depression

Psychology

A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depression

B. Weiss, D. Erritzoe, et al.

This research conducted by Brandon Weiss, David Erritzoe, Bruna Giribaldi, David J Nutt, and Robin L Carhart-Harris delves into the limitations of the Quick Inventory of Depressive Symptomatology while revealing that psilocybin therapy may outperform traditional escitalopram treatment in alleviating major depressive disorder symptoms.

00:00
00:00
Playback language: English
Abstract
This study critically evaluates the Quick Inventory of Depressive Symptomatology, Self-Report, 16 items (QIDS-SR 16) using data from a clinical trial comparing psilocybin therapy (PT) and escitalopram treatment (ET) for major depressive disorder. While 14 of 16 outcome measures favored PT, the QIDS-SR 16 did not. The study investigates reasons for this discrepancy and re-examines between-condition differences at item, facet, and factor levels. Results suggest QIDS-SR 16 limitations, including high variance, imprecise compound items, vague scoring options, and a lack of focus on core depression factors. Re-analysis reveals PT's superiority in reducing depressed mood, anhedonia, and a core depression factor, highlighting potential advantages of PT over ET.
Publisher
Journal of Psychopharmacology
Published On
Jan 01, 2023
Authors
Brandon Weiss, David Erritzoe, Bruna Giribaldi, David J Nutt, Robin L Carhart-Harris
Tags
psilocybin therapy
major depressive disorder
QIDS-SR 16
escitalopram treatment
depression
clinical trial
anhedonia

Related Publications

Explore these studies to deepen your understanding of the subject.

Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial
Psychology

Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial

M. I. Husain, D. M. Blumberger, et al.

Amplification of Positivity Treatment for Anxiety and Depression: A Randomized Experimental Therapeutics Trial Targeting Social Reward Sensitivity to Enhance Social Connectedness
Psychology

Amplification of Positivity Treatment for Anxiety and Depression: A Randomized Experimental Therapeutics Trial Targeting Social Reward Sensitivity to Enhance Social Connectedness

C. T. Taylor, M. B. Stein, et al.

Exploratory analysis of eating- and physical activity-related outcomes from a randomized controlled trial for weight loss maintenance with exercise and liraglutide single or combination treatment
Health and Fitness

Exploratory analysis of eating- and physical activity-related outcomes from a randomized controlled trial for weight loss maintenance with exercise and liraglutide single or combination treatment

S. B. K. Jensen, C. Janus, et al.

Factors associated with the outcomes of a novel virtual reality therapy for military veterans with PTSD: Theory development using a mixed methods analysis
Psychology

Factors associated with the outcomes of a novel virtual reality therapy for military veterans with PTSD: Theory development using a mixed methods analysis

B. Hannigan, R. V. Deursen, et al.

Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny